Department of Biostatistics Archives
Specialty pharmacists help reduce MS relapse risk
Jul. 28, 2022—Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.
Epidemiology PhD program receives CEPH accreditation
Jul. 21, 2022—The Vanderbilt Epidemiology PhD Program has received accreditation from the Council on Education for Public Health (CEPH).
Davidson named to receive the Geoffrey David Chazen Faculty Award for Innovation in Medical Education
Jun. 30, 2022—The Academy for Excellence in Education is pleased to announce Mario Davidson, PhD, is the recipient of the 2022 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.
Grant to help train biostatisticians in West Africa
Jun. 16, 2022—Vanderbilt and Aminu Kano Teaching Hospital have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa.
Capacity-building grant trains biostatisticians in West Africa
Jun. 8, 2022—The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa.
Sex & race & door-to-ECG time
Jun. 2, 2022—More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.
VUMC’s Pietenpol, Shyr named AACR Fellows
Mar. 22, 2022—Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.
Impact of digital health interventions
Jan. 31, 2022—Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
Jan. 14, 2022—A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.
VUMC team puts tool to reduce heart failure admissions to test
Nov. 11, 2021—Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.
VUMC tests drugs for COVID outpatient treatment
Nov. 11, 2021— by Paul Govern Vanderbilt University Medical Center has joined a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a...
Raman, Balucan receive health equity research grants
Sep. 9, 2021—Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.
